Author details

Full Name

Debra Hawes

Affiliation

ORCID

Career Start Year

1992

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37166032	Retinal arterial AÎ² deposition is linked with tight junction loss and cerebral amyloid angiopathy in MCI and AD patients.		2023
37584601	Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.	Cancer Discov	2023
37094128	Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas.	Proc Natl Acad Sci U S A	2023
37333119	Machine Learning Classification of Alzheimer's Disease Pathology Reveals Diffuse Amyloid as a Major Predictor of Cognitive Impairment in Human Hippocampal Subregions.		2023
37198977	Hyaline protoplasmic astrocytopathy in epilepsy.	Neuropathology	2023
36630864	Microstructural mapping of dentate gyrus pathology in Alzheimer's disease: A 16.4 Tesla MRI study.		2023
36620600	Novel MRI deformation-heterogeneity radiomic features are associated with molecular subgroups and overall survival in pediatric medulloblastoma: Preliminary findings from a multi-institutional study.	Front Oncol	2022
35501487	ATRT-SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance.	Acta Neuropathol	2022
36268104	Quantitative Nuclear Histomorphometry Predicts Molecular Subtype and Clinical Outcome in Medulloblastomas: Preliminary Findings.	J Pathol Inform	2022
34613815	Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas.	Sci Transl Med	2021
34162441	Autopsy findings of previously described case of diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma.	Acta Neuropathol Commun	2021
33948563	Clinical utility of comprehensive genomic profiling in central nervous system tumors of children and young adults.	Neurooncol Adv	2021
33563539	Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray project.	Urol Oncol	2021
32406814	Corticospinal Wallerian Degeneration Before Myelination: A Case Report.	Pediatric and Developmental Pathology	2020
32197665	Diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma.	Acta Neuropathol Commun	2020
30948375	Pediatric Atypical Teratoid/Rhabdoid Tumors of the Brain: Identification of Metabolic Subgroups Using In Vivo <sup>1</sup>H-MR Spectroscopy.	AJNR Am J Neuroradiol	2019
30608927	Continuous and bolus intraventricular topotecan prolong survival in a mouse model of leptomeningeal medulloblastoma.	PLoS One	2019
31179415	Rare Pediatric Invasive Gliofibroma Has BRAFV600E Mutation and Transiently Responds to Targeted Therapy Before Progressive Clonal Evolution.	JCO Precis Oncol	2019
28387643	Novel GOPC(FIG)-ROS1 fusion in a pediatric high-grade glioma survivor.	J Neurosurg Pediatr	2017
28733933	Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome.	Acta Neuropathol	2017
26276750	Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic Density.	Cancer Prev Res (Phila)	2015
24648349	Differential effects of RUNX2 on the androgen receptor in prostate cancer: synergistic stimulation of a gene set exemplified by SNAI2 and subsequent invasiveness.	Cancer Res	2014
25278449	Phase I, dose-escalation study of the targeted cytotoxic LHRH analog AEZS-108 in patients with castration- and taxane-resistant prostate cancer.	Clin Cancer Res	2014
23772639	Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era.	Leukemia and Lymphoma	2014
23607450	Epstein-Barr virus patterns in US Burkitt lymphoma tumors from the SEER residual tissue repository during 1979-2009.	APMIS	2014
23319010	Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance Program.	Cancer	2013
24380073	Biological effects of green tea capsule supplementation in pre-surgery postmenopausal breast cancer patients.	Front Oncol	2013
22083231	Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation.	Breast Cancer Res Treat	2012
22325110	Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial.	Contraception	2012
22110216	Ethnic differences in neuroendocrine expression in prostate cancer tissue.	Anticancer Research	2011
21456071	Effect of luteinizing hormone on the steroidogenic pathway in prostate cancer.	Prostate	2011
21809992	Effects of the change in cutoff values for human epidermal growth factor receptor 2 status by immunohistochemistry and fluorescence in situ hybridization: a study comparing conventional brightfield microscopy, image analysis-assisted microscopy, and inter		2011
21791687	Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer.	JAMA	2011
21990404	Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial.	Journal of Clinical Oncology	2011
20670943	Expression of receptors for luteinizing hormone-releasing hormone (LH-RH) in prostate cancers following therapy with LH-RH agonists.	Clin Cancer Res	2010
19205874	Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast.	Breast Cancer Res Treat	2009
19366806	Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression.	Cancer Res	2009
18383880	Prognostic value of the androgen receptor and its coactivators in patients with D1 prostate cancer.	Anticancer Research	2008
17640713	Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival.	Human Pathology	2007
16646977	Dense breast stromal tissue shows greatly increased concentration of breast epithelium but no increase in its proliferative activity.	Breast Cancer Res	2006
16515971	Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer.	J Urol	2006
17020963	Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.	Clinical Cancer Research	2006
16816380	Receptor tyrosine kinase EphB4 is a survival factor in breast cancer.	Am J Pathol	2006
17062670	Expression of stress response protein Grp78 is associated with the development of castration-resistant prostate cancer.	Clinical Cancer Research	2006
16782914	Detection of occult lymph node metastases in locally advanced node-negative prostate cancer.	Journal of Clinical Oncology	2006
15041797	Anti-angiogenic activity of contortrostatin, a disintegrin from Agkistrodon contortrix contortrix snake venom.	Angiogenesis	2003
12468337	Correlation of p53 immunostaining in primary and residual ovarian cancer at the time of positive second-look laparotomy and its prognostic role: a Southwest Oncology Group ancillary study.	Gynecologic Oncology	2002
11796289	Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression.	Urology	2002
11747273	Detection of occult metastasis in patients with breast cancer.	Seminars in Surgical Oncology	2001
11599903	Occult metastases in patients with breast cancer.	Annals of Surgical Oncology	2001